Shares of Eli Lilly ticked downward after a fake account posed as the company on Twitter.
JARED BLIKRE: Eli Lilly, that is my pick of the day. Healthcare taking a backseat in today's rally, as defensive sectors lag. And here we go because guess what? This company, too, got caught up in the maelstrom. They're dealing with an impostor account on Twitter. And earlier, that impostor account said free insulin for all. This was false.
And the company is issuing a response, in which it reads, quote, "We apologize to those who have been served a misleading message from a fake Lilly account. Our official Twitter account is @lillypad." All of this is a microcosm of the chaos at Twitter as Elon Musk's push for Twitter Blue subscriptions hit a roadblock, to say the least, as we were just talking about, Dave, with Dan Howley.
DAVE BRIGGS: Is there a fake Jared Blikre account out there with fake charts going on? You need to keep your eye on that.
JARED BLIKRE: I will. I will man that.
DAVE BRIGGS: I'm a big believer in Eli Lilly because of that Mounjaro, that diabetes weight loss drug, could be revolutionary. Fast track status from the FDA, so that you can, indeed, believe.